TY - JOUR
TI - Reply to the letter to the editor 'The ESMO magnitude of clinical benefit scaling tool: From theory to practice' by Hartmann and the letter 'Comment on ESMO magnitude of clinical benefit scale' by Muhonen et al.
AU - Cherny, N.I.
AU - Sullivan, R.
AU - Dafni, U.
AU - Kerst, J.M.
AU - Sobrero, A.
AU - Zielinski, C.
AU - De Vries, E.G.E.
AU - Piccart, M.J.
JO - Annals of Oncology
PY - 2016
VL - 27
TODO - 1
SP - 203-205
PB - Oxford University Press
SN - 0923-7534, 1569-8041
TODO - 10.1093/annonc/mdv502
TODO - analytical research;  attitude to health;  biomedical technology assessment;  clinical assessment tool;  clinical benefit scaling tool;  clinical effectiveness;  clinical evaluation;  confidence interval;  health care policy;  health hazard;  health service;  health technology assessment;  human;  Israel;  Letter;  oncology;  overall survival;  practice guideline;  priority journal;  quality of life;  reimbursement;  statistical analysis;  Neoplasms;  outcome assessment;  procedures, Humans;  Neoplasms;  Outcome Assessment (Health Care)
TODO - null
ER -